Tadalafil 20 - Livewell Pharmaceuticals

Tadalafil emerged from cardiovascular research in the early 1990s and was patented in 1994 as IC351. Its development accelerated through a partnership between ICOS and Eli Lilly, leading to its 2003 FDA approval as Cialis. Unlike earlier treatments, tadalafil’s structure grants it a long duration of up to 36 hours, with fewer side effects than its peers. It redefined ED therapy by offering once-daily dosing and sustained efficacy. Tadalafil’s success reflects a broader shift in men’s health—toward treatment approaches that prioritize both effectiveness and quality of life.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Tadalafil 20 by Livewell Pharmaceuticals, consult with your doctor or healthcare professional.